The 6th China International Import Expo showcases its attractiveness, and Boston's science is being updated on a large scale
我放心你带套猛
发表于 2023-11-6 09:51:01
306
0
0
Bringing all the products that have won the Galen Award or been nominated by him over the years to the CIIE, bringing all the new products developed globally to the stage of CIIE. Many of the exhibits are "the world's first" and "China's first exhibition"... As soon as the 6th China International Import Expo opened, the Boston Science Expo attracted attention from all walks of life with its ultra-high "innovation concentration".
During an interview with a reporter from China News Agency, Zhang Cheng, the head of the R&D department and the port factory in Boston Science China, Using "old friends" and "loyal fans" to describe the relationship between Boston Science and the CIIE: "Participating in the CIIE for five years is also a 'golden five years' for Boston Science to accelerate its localization in China. We not only welcomed the landing of our first domestically produced product, but also upgraded our identity as an' exhibitor to investor '. At the same time, more and more products have achieved the transformation from exhibits to products and then to explosive products
On November 5th, Zhang Cheng, the head of the R&D department and port factory in Boston's Science China region, gave an exclusive interview to reporters from China News Agency. Photographed by Tang Yanjun, a journalist from China News Agency
Zhang Cheng introduced that during this CIIE, Boston Science brought over 70 exhibits, of which nearly half have not yet been listed in mainland China. Such a large-scale "new" exhibition is precisely because "CIIE demonstrates the strong resilience of the Chinese economy and the attractiveness of a super large market size".
On the one hand, thanks to the "acceleration effect" of the CIIE, the global cutting-edge technologies exhibited by Boston Science have entered the "fast lane" of accelerated landing.
The intravascular ultrasound system we exhibited during our first exhibition at the Expo attracted the attention of relevant departments. With the innovative policy support of the Medical Device Marketing License Holder System (MAH), we obtained a local registration certificate last year, achieved localization, and synchronized global supply. We completed the three steps of 'from import to domestic and then to export' on the Expo stage, "said Zhang Cheng.
On the other hand, with the help of the "first and first try" system of the China Free Trade Zone and the China International Expo, Boston Science participated in the exhibition for the first time and started a series of cooperation with the Boao Lecheng International Medical Tourism Pilot Zone. In the past few years, 6 products have been launched in this pilot zone for "first trial", 4 products have entered real world research, and even set a record of "the world's first approved launch".
This has allowed Boston Science, which has grown together with the Chinese medical industry in the past 30 years, to once again gain new development opportunities and continuously enhance its confidence in being rooted in China.
We are continuously increasing our investment in China and expanding to both ends of the industrial value chain, "said Zhang Cheng. In October of this year, Boston Science announced the establishment of the first production and manufacturing base in Shanghai, further deepening the localization layout and enhancing local supply chain capabilities.
For Boston Science, China plays an indispensable and important role in the global supply chain. The layout of the first self owned production line and the acceleration of local production are also key steps in the headquarters' global strategic layout, "said Zhang Cheng. Firstly, local manufacturing is used to help improve the accessibility of cutting-edge medical technology in the Chinese market, while also looking forward to the future" Made in China "benefiting global patients.
Not only that, "Chinese innovation" is also integrating with global innovation through the Boston Science Bridge. Zhang Cheng introduced that as early as 2010, Boston Science established its first overseas research and development center in Shanghai. Over the past 10 years, it has built a multidisciplinary research and development team consisting of more than 120 local engineers. "Now, this local research and development team has become one of the core forces of Boston Science's global research and development, and has received the company's highest global research and development honors and commendations multiple times
Boston Science aims to achieve effective innovation centered on patient needs, which also means that research and development that is close to the local market is an important part of our comprehensive localization strategy, "said Zhang Cheng. In recent years, Boston Science has also conducted strategic cooperation with many Chinese medical enterprises, conducted in-depth exchanges in the research and development field, and actively explored and promoted more Chinese innovation to the world.
In Zhang Cheng's view, China's medical innovation environment is facing unprecedented new opportunities. "The innovation ecosystem has entered an era of blooming flowers," and Boston Science is actively working with China's industry, university, research and medical partners to explore the integration of medicine and industry and innovation transformation, deeply rooted in this ecosystem.
When it comes to the outlook for the Chinese market, Zhang Cheng stated that China is one of the most attractive medical technology markets in the world, with unparalleled growth space, market size, and innovation ecology, The Chinese medical device market has become the second largest in the world, but the unmet medical demand is still enormous. We hope to adhere to 'innovation' and 'localization' in this market full of potential and vitality, and use our high-quality resources to deeply integrate and collaborate with the local ecosystem in all aspects of the medical industry value chain, so that our development in China can go deeper and further
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Huazhu Group's debut at the CIIE: showcasing China's hotel business card to the world
- Honeywell: Continuous investment in Chinese innovation team | CIIE
- Seven years of sharing innovation opportunities with peers, Johnson&Johnson Medical Technology Orthopedics presents multiple new products at the CIIE
- Wu Mingxia, General Manager of Micron Technology China: Continuing to invest in Xi'an's new factory in China and introducing a new production line | Interview with CIIE
- Assisting Silver Hair Health, Abbott showcases cutting-edge life technology at the CIIE
- Exhibitors in the Expo with innovative achievements to help diabetes intelligent management
- Interview with Boston Scientific's Gong Wenhao: Proactively embracing the national centralized procurement policy and accelerating the sinking of high-quality medical resources
- Exploring the CIIE | New products from Sinogen, Roche, and Pfizer become highlights of the CIIE
- Procter&Gamble Chain Expo releases' Supply Chain Value Community 'strategy
- Goldman Sachs: Increases Boston Scientific's target price to $103
